Co-regulation of histone-modifying enzymes in cancer.
Cancer is characterized by aberrant patterns of expression of multiple genes. These major shifts in gene expression are believed to be due to not only genetic but also epigenetic changes. The epigenetic changes are communicated through chemical modifications, including histone modifications. However...
Main Authors: | Abul B M M K Islam, William F Richter, Laura A Jacobs, Nuria Lopez-Bigas, Elizaveta V Benevolenskaya |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3160334?pdf=render |
Similar Items
-
Histone Modifying Enzymes in Gynaecological Cancers
by: Priya Ramarao-Milne, et al.
Published: (2021-02-01) -
Ubiquitin Regulation: The Histone Modifying Enzyme′s Story
by: Jianlin Wang, et al.
Published: (2018-08-01) -
Expression of histone modifying enzymes and histone post-translational marks in colorectal cancer
by: António José Polónia Rodrigues de Oliveira
Published: (2019) -
Chromatin regulation in schistosomes and histone modifying enzymes as drug targets
by: Raymond John Pierce, et al.
Published: (2011-11-01) -
Functional role of G9a histone modifying enzymes in cancer
by: Francesco eCasciello, et al.
Published: (2015-09-01)